 |
|
Biomarkers for Mortality and Cardiovascular Events
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
To the Editor: Dr Kistorp and colleagues1 determined the predictive value of 3 emerging biomarkers for total mortality and cardiovascular end points, N-amino terminal fragment of the prohormone brain natriuretic peptide (NT-proBNP), C-reactive protein (CRP), and the albumin/creatinine ratio in urine. Studying 626 participants with mean age of 68 years from the general population without overt heart failure or renal failure, Kistorp et al found the strongest association was between NT-proBNP and these end points, followed by the albumin/creatinine ratio in urine. CRP was not independently associated with total mortality or with cardiovascular end points, and the authors concluded that CRP may not contribute to risk prediction in older nonhospitalized participants. There are 2 issues that might limit their conclusions and the generalizability of the results.
First, the majority of participants in the study were older women, and more than 40% had either coronary heart disease, arterial hypertension, or type . . . [Full Text of this Article]
Wolfgang Koenig, MD
wolfgang.koenig@medizin.uni-ulm.de
University of Ulm Medical Center
Ulm, Germany
RELATED ARTICLES
Biomarkers for Mortality and Cardiovascular Events—Reply
Caroline Kistorp, Ilan Raymond, Frants Pedersen, Finn Gustafsson, Jens Faber, and Per Hildebrandt
JAMA. 2005;294(3):303-304.
EXTRACT
| FULL TEXT
N-Terminal Pro-Brain Natriuretic Peptide, C-Reactive Protein, and Urinary Albumin Levels as Predictors of Mortality and Cardiovascular Events in Older Adults
Caroline Kistorp, Ilan Raymond, Frants Pedersen, Finn Gustafsson, Jens Faber, and Per Hildebrandt
JAMA. 2005;293(13):1609-1616.
ABSTRACT
| FULL TEXT
|
